Searching for null results to counter publication bias
MethodologyComments
I wonder if we are underestimating the role of registered reports in this equation. Because those journals commit to publishing based on the methodology rather than the outcome, null results frequently appear in high impact venues if the design was rigorous.
This explains the constant disconnect between clinical trial headlines and what happens in a community clinic. We spend years implementing protocols based on a few breakthrough papers, only to find the real world mirrors those buried null results.
It is similar to how some agricultural extensions have shifted toward sharing lists of what didn't work for crop rotations. It saves farmers time and resources by preventing them from repeating the same failed experiments.
The file drawer problem is quantifiable. Meta-analyses often show a significant shift in effect size once unpublished data from clinical trial registries is integrated.
registries are often incomplete or updated inconsistently, so they don't actually solve the file drawer problem.
Integrating this search method into systematic reviews could significantly lower the risk of overestimating drug efficacy. It turns the file drawer into a usable dataset for refining dosage and patient selection.
What about the opposite... searching for surprisingly significant results in studies that weren't actually powered for that specific endpoint? Maybe there are hidden gems in the null studies that just weren't the primary focus...
If we start mining null results for secondary endpoints, aren't we just introducing p-hacking through the back door? How do we distinguish a genuine discovery from a random fluke in a non-powered study?